Bluestone Trials

Single posterior (back) dental implant

Do you need a single posterior (back) dental implant placed?
Status: Completed.

Interested subjects are being asked to participate in this study because they need to have a single posterior (back) dental implant placed.

The purpose of this study is to evaluate the effectiveness of a collagen material membrane, that when used during the surgical process of the dental implant placement, may increase the thickness and size of thegums around dental implants. This graft material will be placed in one implant site only. The other implant site will receive the standard of treatment.

This study will be conducted at the NYU Bluestone Center for Clinical Research and requires that you be willing to comply with study procedures. To qualify for this study, you need to be 18 years old or older and are required to receive an oral screening by the study investigators in addition to other study specific eligibility requirements.

Study Details: 

This study consists of approximately 6 visits to our study site, over a 4-month period. Each visit will last approximately 1.5 hours. There will be no cost for treatment for eligible participants for the surgical procedure of the implant placement.

Dental implants are used as a treatment option for replacing missing teeth.  Rather than resting on the gum line like removable dentures or using adjacent teeth as anchors like fixed bridges, dental implants can be surgically placed inside the jawbone to create an artificial tooth that will later receive the prosthetic treatment (crown).

Dentists believe it is better to have thicker gums around dental implants. Graft materials are usually membranes of pure collagen, which may or may not be placed around the implants. These membranes can help with the regeneration of oral mucosa and gingival, which may increase the thickness and size of your gums around dental implants.  After it is used, the membrane is gradually absorbed, and it is slowly replaced with the normal gingival tissue.

The membrane used for this study has been approved by the Food and Drug Administration (FDA) for treating oral soft tissue defects.